Nature's Sunshine delivered a strong second quarter in 2025, with net sales increasing by 4% to $114.8 million and adjusted EBITDA rising by 8% to $11.3 million year-over-year. The company saw particular strength in Asia and North America, alongside improvements in gross profit margin and a decrease in volume incentives as a percentage of net sales.
Net sales increased by 4% to $114.8 million in Q2 2025 compared to $110.6 million in the same period last year.
GAAP net income attributable to common shareholders significantly increased to $5.3 million, or $0.28 per diluted common share, from $1.3 million, or $0.07 per diluted common share, in Q2 2024.
Adjusted EBITDA grew by 8% to $11.3 million, up from $10.4 million in the prior year quarter, primarily driven by increased net sales.
Gross profit margin improved to 71.7% in Q2 2025 from 71.4% in Q2 2024, attributed to cost savings initiatives.
Nature's Sunshine has raised its full-year 2025 net sales and adjusted EBITDA guidance, reflecting confidence in continued growth despite macroeconomic uncertainties.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance